Highest-materiality recent filing
Selectis Health completes merger with Black Pearl Equities II; shareholders receive $5.75 per share
On October 5, 2026, Merger Sub merged into Selectis Health, Inc.; Selectis became a wholly owned subsidiary of Black Pearl Equities II, LLC and an indirect subsidiary of Parent.
Black Pearl completes tender offer for Selectis Health at $5.75/share; 90.93% tendered
2,789,027 shares (90.93%) validly tendered; all conditions satisfied, payment to proceed.
Selectis Health to be acquired by Black Pearl for $5.75 per share in cash
Selectis Health stockholders to receive $5.75 per share in cash in acquisition by Black Pearl Equities affiliates.
CEO/CFO Adam Desmond resigns; Krystal Eckhart appointed interim CEO and CFO
Adam Desmond resigned as CEO, CFO, and board member effective May 14, 2026.
Selectis Health sells two Georgia SNFs for $15.7M; net proceeds ~$9M
Sold Glen Eagle Healthcare (101-bed, Abbeville) and Eastman Healthcare (100-bed) to GA SNF entities.
Selectis Health board member David Furstenberg resigns effective March 30, 2026
David Furstenberg resigned from the Board of Directors and Audit Committee on March 30, 2026.
Selectis Health appoints Richard Huebner to Board of Directors effective March 12, 2026
Richard Huebner, age 68, appointed to Selectis Health Board effective March 12, 2026.
Selectis Health agrees to sell two Georgia skilled nursing facilities for $15.7M
Purchase price $15.7M for Glen Eagle (101-bed) and Eastman (100-bed) facilities in Georgia.
Selectis Health sells two Georgia skilled nursing facilities for $13.175 million
Sold Sparta (71-bed) and Warrenton (110-bed) facilities for aggregate $13.175M; escrow of $1.3M.
Selectis Health appoints Kent Lund and Lance Baller to Board of Directors
Effective January 1, 2026, Board appointed Kent Lund, age 70, with legal/securities background and former FINRA committee member.
Selectis Health extends $1.775M notes to Feb 2026, interest rate raised to 13%
Maturity extended to Feb 28, 2026 or earlier upon Qualified Transaction; 30-day extensions possible with 0.5% fee.
Selectis Health agrees to sell two Georgia skilled nursing facilities for $13.175M
Total purchase price $13,175,000 for 71-bed Sparta and 110-bed Warrenton facilities.
Purchaser terminated the Purchase and Sale Agreement and Operations Transfer Agreement for Georgia subsidiaries effective July 13, 2025.
Selectis Health's common stock approved for OTCQB quotation effective June 23
Received OTC Markets approval for upgraded quotation on the OTCQB tier.
Selectis Health signs $27M deal to sell four Georgia skilled nursing facilities
Purchase agreements cover Glen Eagle (101 beds), Eastman (100 beds), Sparta (71 beds), and Warrenton (110 beds).
CFO James Creamer resigns; CEO Adam Desmond named interim CFO
James Creamer resigned as CFO effective January 17, 2025, under a separation agreement.
Selectis Health appoints WithumSmith+Brown as new independent auditor
Effective Dec 4, 2024, Board and Audit Committee appointed WithumSmith+Brown, PC as independent registered public accounting firm.
Selectis Health's auditor Marcum LLP resigns; going concern opinion issued for 2022/2023
Marcum LLP terminated as independent auditor effective November 20, 2024.
Selectis Health raises CEO salary to $250K; CEO waives $30K board stipend
CEO Adam Desmond's salary increased from $150,000 to $250,000 per annum, effective October 1, 2024.
Selectis Health appoints James Creamer as CFO, effective Aug 15, 2024
Creamer appointed CFO effective Aug 15, 2024; base salary $180,000/year.
Director Andrew Sink resigns from Selectis Health Board effective June 30, 2024
Andrew Sink resigned as director, effective June 30, 2024; resignation tendered June 24.
Selectis Health sells Georgia skilled nursing facility for $6.75M, reduces debt
Sold Archway Transitional Care Center 1 in Macon, GA for $6.75M; buyer was lessee since 2016.
Selectis Health signs definitive agreement to sell Archway nursing facility for $6.75M
Wholly-owned subsidiary Goodwill Hunting, LLC (seller) entered PSA to sell Archway Property in Macon, GA to Bibb County Holdings II, LLC for $6.75M.
Selectis Health subsidiary agrees to sell Archway Transitional Care Center for $6.75M
Purchase price of $6,750,000 for skilled nursing facility in Macon, GA.
Selectis Health secures $750K line of credit at 8.5% due April 2025
Entered into Commercial Line of Credit Agreement and Note with Southern Bank for $750,000 principal limit.
Selectis Health Board approves standard Indemnity Agreement for directors and officers
Board approved form of Indemnity Agreement effective March 18, 2024, for all directors and officers.
Selectis Health appoints Adam Desmond as permanent CEO effective March 18, 2024
Board of Directors appointed Adam Desmond as Chief Executive Officer, effective March 18, 2024.
Selectis Health's sale of Georgia subsidiaries terminated by purchaser; company denies defaults
Effective Feb 20, 2024, Purchaser terminated the Purchase & Sale and Operations Transfer Agreements for certain Georgia subsidiaries without consummation.
Selectis Health appoints Jim Creamer interim CFO, Clifford Neuman to board
Jim Creamer appointed Interim CFO effective Dec 18, 2023; annual salary $120,000.
Selectis Health agrees to sell four Georgia skilled nursing facilities for $31M
Sale of Warrenton, Eastman, Glen Eagle, and Sparta facilities for $31M aggregate consideration.
CEO Lance Baller resigns; board member Adam Desmond named Interim CEO
Lance J. Baller resigned as CEO, acting principal financial officer, and director effective Nov 13, 2023 or earlier upon replacement.
Selectis Health President and COO Christopher Barker resigns effective May 31 due to health issues
Christopher 'Randy' Barker resigned as President, COO, and board member effective May 31, 2023.
CFO Christine Lucus resigns effective April 5, 2023; CEO Lance Baller interim PFO
Christine Lucus resigned as CFO, effective April 5, 2023.
Selectis Health annual meeting elects Andy Sink as Class I director, ratifies Marcum LLP as auditor
Andy Sink elected as Class I director with 1,270,541 For, 41,080 Withheld, and 209,377 broker non-votes.
Selectis Health presents at Rocky Mountain MicroCap Conference on Nov 10, 2022
Investor presentation furnished as Exhibit 99.1; no specific financial results disclosed in the filing.
Selectis Health appoints Mary Christine Lucus as Secretary, replacing Clifford Neuman
Mary Christine Lucus appointed as Secretary effective October 31, 2022.
Selectis Health presents at LD Micro Main Event; no material financial updates in filing
Company presented its October 25, 2022 investor presentation at the LD Micro Main Event Conference VIII.
Selectis Health appoints Andrew Sink to board; Clifford Neuman resigns as director and secretary
Andrew Sink appointed independent director effective Oct 17, 2022, filling vacancy from Clifford Neuman's resignation.
Director Clifford Neuman resigns; Andrew Sink appointed to board
Effective Oct 17, 2022, Clifford Neuman resigned as director and secretary of Selectis Health.
Selectis Health appoints Marcum LLP as new auditor, replacing Haynie & Company
Former auditor Haynie & Company dismissed; no accounting disagreements, only previously reported material weaknesses.
Selectis Health Q2 revenue up 91% to $11.5M; net income $1.0M vs loss year ago
Q2 2022 revenue $11.5M (record), up 91% YoY; net income $1.0M ($0.34 per share) vs net loss of $0.7M.
Clifford Neuman resigned from the Audit, Compensation, and Nomination and Governance Committees effective August 18, 2022.
Selectis Health adopts committee charters and appoints standing committee members
Board adopted Audit, Compensation, and Nominating & Governance Committee Charters on July 25, 2022.
Selectis Health appoints David J. Furstenberg to Board of Directors
Appointment effective July 1, 2022; Furstenberg will serve as a director.
Selectis Health grants 200,000 stock options to CEO and President/COO at $7.00
CEO Lance Baller and Randy Barker each received options for 100,000 shares at $7.00 exercise price.
Selectis Health CFO Brandon Thall resigns; Controller Christine Lucus named interim CFO
Brandon Thall resigned as CFO effective March 4, 2022; immediate departure.
Selectis Health dismisses MaloneBailey as auditor, appoints Haynie & Company
Board approved auditor change effective Jan 26, 2022; MaloneBailey dismissed, Haynie & Company engaged.
Selectis Health converts $795K of 11% Notes to 159K shares to boost net equity above $4M
Converted additional $165K in 11% Senior Secured Notes for 33K shares at $5/share on Jan 17, 2022.
Selectis Health grants 30,000-share option at $6.00 to Gateway Group for IR; $6,000 monthly fee
Option to purchase 30,000 shares at $6.00 per share, fully vested, exercisable for 3 years with cashless exercise provision.
Selectis Health exchanges $640K debt for 128K shares at $5/share to boost equity for listing
Exchanged $640K principal of 2018 11% Senior Secured Promissory Notes for 128K common shares at $5.00/share.
In accordance with Section 2.10 of the Merger Agreement, at the Effective Time, each of Clifford L. Neuman, Kent J. Lund, and Richard Huebner ceased to serve as a member of the Board of Directors of the Company (the “Board”) and of any committee of the Board, and Krystal Eckhart ceased to serve as Interim Chief Financial Officer of the Company.
In accordance with Section 2.10 of the Merger Agreement, at the Effective Time, Abraham Schwartz and Zalman Schapiro, being the directors of Merger Sub immediately prior to the Effective Time, became the directors of the Company, and Abraham Schwartz and Zalman Schapiro, being the officers of Merger Sub immediately prior to the Effective Time, became the officers of the Company.
and Abraham Schwartz and Zalman Schapiro, being the officers of Merger Sub immediately prior to the Effective Time, became the officers of the Company.
In accordance with Section 2.10 of the Merger Agreement, at the Effective Time, Abraham Schwartz and Zalman Schapiro, being the directors of Merger Sub immediately prior to the Effective Time, became the directors of the Company, and Abraham Schwartz and Zalman Schapiro, being the officers of Merger Sub immediately prior to the Effective Time, became the officers of the Company.
In accordance with Section 2.10 of the Merger Agreement, at the Effective Time, each of Clifford L. Neuman, Kent J. Lund, and Richard Huebner ceased to serve as a member of the Board of Directors of the Company (the “Board”) and of any committee of the Board, and Krystal Eckhart ceased to serve as Interim Chief Financial Officer of the Company.
In accordance with Section 2.10 of the Merger Agreement, at the Effective Time, each of Clifford L. Neuman, Kent J. Lund, and Richard Huebner ceased to serve as a member of the Board of Directors of the Company (the “Board”) and of any committee of the Board, and Krystal Eckhart ceased to serve as Interim Chief Financial Officer of the Company.
and Abraham Schwartz and Zalman Schapiro, being the officers of Merger Sub immediately prior to the Effective Time, became the officers of the Company.
In accordance with Section 2.10 of the Merger Agreement, at the Effective Time, each of Clifford L. Neuman, Kent J. Lund, and Richard Huebner ceased to serve as a member of the Board of Directors of the Company (the “Board”) and of any committee of the Board, and Krystal Eckhart ceased to serve as Interim Chief Financial Officer of the Company.
On May 15, 2026, the Board of Directors of the Company appointed Krystal Eckhart to serve as the Company’s Interim CEO and CFO.
Effective May 14, 2026 the Board of Directors of Selectis Health, Inc., a Utah corporation (the “Company”) and Adam Desmond (“Desmond”) agreed that he would resign all positions with the Company including CEO, CFO of the Company and a member of the Board of Directors.
Adam Desmond, the Company’s current CEO, will serve as the Interim CFO until a permanent CFO is identified.
On January 17, 2025, James Creamer tendered his resignation as Chief Financial Officer of Selectis Health, Inc. (the “Company”), pursuant to a Separation Agreement and Release of even date.
Max materiality 1.00 · Median 0.50 · Most common event leadership